CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro

Alishah, KahdijehBirtel, MatthiasMasoumi, ElhamJafarzadeh, LeilaMirzaee, Hamid RezaHadjati, JamshidVoss, Ralf-HolgerDiken, MustafaAsad, Sedighe2022-08-102022-08-102021https://openscience.ub.uni-mainz.de/handle/20.500.12030/7560engCC-BY-4.0https://creativecommons.org/licenses/by/4.0/610 Medizin610 Medical sciencesCRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitroZeitschriftenaufsatz